The Lymphatic System of the Brain (Glymphatic and Meningeal Lymphatics): Implications for Waste Clearance and Immunosurveillance View PDF

The lymphatic system of the brain, encompassing the glymphatic pathway and meningeal lymphatic vessels, has emerged as a critical component in maintaining cerebral homeostasis through waste clearance and immunosurveillance [1-10]. Recent advances, as summarized in multiple studies, have significantly expanded our understanding of these systems’ anatomy, physiology, and their implications in neurological health and disease (Figure 1) [6].

The glymphatic system, a perivascular network facilitating the exchange of cerebrospinal fluid (CSF) and interstitial fluid (ISF), plays a pivotal role in removing metabolic waste products from the brain parenchyma. Yankova et al. [3] highlights the recent characterization of the glymphatic pathway and its close relationship with meningeal lymphatic vessels, emphasizing their integrated function in CNS clearance. The system’s reliance on astrocytic aquaporin-4 channels underscores its cellular basis, facilitating fluid movement along perivascular spaces [11]. This pathway enables the brain to efficiently clear neurotoxic substances such as amyloid-β, which is particularly relevant in neurodegenerative diseases like Alzheimer’s disease. Complementing the glymphatic pathway, meningeal lymphatic vessels provide an anatomical route for waste drainage from the CNS to peripheral lymph nodes. The discovery of these vessels has refined the traditional view that the brain lacks a lymphatic system, revealing a specialized network that communicates with systemic immune responses [12]. Imaging techniques, including diffusion tensor imaging along the perivascular space (DTI-ALPS), have been instrumental in visualizing these pathways and assessing their function in vivo [13]. Zhang et al. [13] also discusses the potential of enlarged perivascular spaces as neuroimaging biomarkers, reflecting alterations in glymphatic and meningeal lymphatic function in various neurological conditions.

The functional dynamics of these systems are influenced by physiological factors such as arterial pulsatility, respiration, and neural activity. For instance, Ozturk et al. [14] demonstrated that positive airway pressure enhances CSF flow and glymphatic transport, indicating that respiratory support can modulate brain waste clearance. Similarly, physical exercise has been shown to promote meningeal lymphatic flow, suggesting lifestyle factors can influence these clearance pathways [15]. These findings underscore the importance of systemic physiological states in regulating CNS lymphatic function. Pathological conditions, including neuroinflammation, stroke, and neurodegenerative diseases, are associated with impaired glymphatic and meningeal lymphatic function. Hsu et al. [16] propose that neuroinflammation-driven lymphangiogenesis may be a double-edged sword, potentially offering therapeutic targets but also contributing to disease progression. In particular, the accumulation of waste products and immune cells due to dysfunctional clearance systems can exacerbate neurodegeneration. Bah et al. [17] emphasize that aging-related decline in these pathways correlates with increased susceptibility to dementia, including Alzheimer’s disease, highlighting the systems’ relevance in age-related neurovascular and neurodegenerative pathologies.

The clinical implications of these systems extend to cerebrovascular diseases such as stroke and small vessel disease. Wang et al. [18] review how lymphatic drainage pathways influence brain injury outcomes post-ischemia, suggesting that enhancing lymphatic function could be a novel therapeutic strategy. Similarly, Tian et al. [19] provides a framework linking glymphatic and meningeal lymphatic dysfunction to the progression of cerebral small vessel disease, which is a major contributor to vascular cognitive impairment. These insights point toward the potential of targeting lymphatic pathways to mitigate disease progression and improve neurological outcomes. Emerging therapeutic approaches aim to modulate these clearance systems. Salehpour et al. [20] discuss photobiomodulation therapy as a promising method to augment glymphatic function, particularly in removing amyloid-β. Additionally, Murdock et al. [21] demonstrates that multisensory gamma stimulation can enhance glymphatic clearance, offering a noninvasive intervention to facilitate waste removal. Pharmacological and mechanical interventions, such as continuous positive airway pressure, have also been shown to improve CSF flow and glymphatic transport [14], further emphasizing the therapeutic potential of modulating these pathways.

The cellular components involved in these systems are integral to their function. Smyth et al. [22] detail the cellular contributions, including glial cells and immune cells, to waste clearance processes. The interaction between neural cells, such as microglia and astrocytes, and the lymphatic structures underscores a complex neuroimmune interface that regulates both waste removal and immune surveillance [23]. This interplay is crucial for understanding how dysfunctions in cellular mechanisms contribute to disease states.

In summary, the recent research underscores the significance of the brain’s lymphatic system, comprising the glymphatic pathway and meningeal lymphatics, in maintaining neural health through efficient waste clearance and immune regulation. These systems are dynamically regulated by physiological factors and are susceptible to impairment in various neurological diseases. Advances in imaging, physiological modulation, and cellular understanding are paving the way for novel therapeutic strategies aimed at restoring or enhancing these clearance pathways, with promising implications for neurodegenerative, cerebrovascular, and neuroinflammatory conditions. As research continues to elucidate the detailed mechanisms and systemic interactions, the lymphatic system of the brain stands out as a vital frontier in neuroscience and clinical neurology.